Four Rivers Signs Lease Agreement with Grean Technologies for STT(R) Reactor System
* Reuters is not responsible for the content in this press release.
Four Rivers Signs Lease Agreement with Grean Technologies for STT(R) Reactor
System
CALVERT CITY, KY, Nov. 30 /PRNewswire-FirstCall/ - Four Rivers BioEnergy Inc.
(OTCBB: FRBE) ("4Rivers" or "Four Rivers" or "the Company") today announced
that the Company has entered into a lease agreement with purchase options with
Grean Technologies of Hamilton, Ohio for a Four Rivers STT(R) Reactor System.
Grean Technologies will be using the system for process intensification
research for their flavors and fragrances business. The 4Rivers STT(R) Reactor
System to be supplied is a 100ml volume system and was part of the assets
acquired by 4Rivers from Kreido BioFuels, Inc. in March 2009.
Gary Hudson, Managing Director of the STT Business and Senior Vice President
of Operations for Four Rivers stated, "This is another significant step in the
commercialization of the STT(R) Reactor System. We are in the process of
establishing a world wide network of agents to bring this technology to
market."
David Moats, Principal of Grean Technologies stated, "We are excited to
enhance our flavor and aroma productions with cutting edge technologies like
the STT system. Having seen the bench-top Magellan STT system at the US EPA
labs in Cincinnati, OH, we have leased the larger Innovator STT system.
This system will be utilized to provide sampling and small production runs
before moving to full commercial scale quantities. The Innovator SST system
will allow Grean Technologies to supply our clients with quality products
while passing along cost efficiencies and reducing the environmental impact of
chemical production."
STT(R) Reactor Systems are based on extensively tested and proven cutting edge
process intensification technology developed over the past 10 years. The
system has a myriad of industrial applications for the bioenergy, chemical,
pharmaceutical, food, flavors, fragrances, nanotechnology, and other
industries.
STT(R) technology creates significant increases in reaction rates where
momentum, heat or mass transfers are involved. A significant benefit of the
STT(R) technology is that optimization can be determined on the bench scale
(Magellan(R) series), which then easily scales up through the pilot production
(Innovator(R) series) and then into the commercial scale.
Some of the advantages that the STT(R) reactor technology brings include:
- Rate enhancement
- Improved conversion
- Selectivity enhancement
- Continuous processing versus batch
- Improved temperature and reaction environment control
- Reduced catalyst consumption and solvent use
- Reaction of normally immiscible materials
- Mixing of materials with large relative viscosities
- Improved safety in handling toxic and explosive materials
- Rapid and efficient cleaning
- Small reactor foot print compared to conventional reactors
The STT(R) Reactor System is based on 4Rivers' own intellectual property and
relies on technology and a combination of 12 issued patents, additional
patents pending, copyright, trade secret laws, and know-how.
For more information on STT(R) Technology, visit http://www.riv4ers.com and
click on STT Technology.
About Four Rivers
Four Rivers BioEnergy, Inc., is realizing the potential of biofuel and
renewable energy by utilizing financial and operational expertise to aggregate
biofuel and renewable energy assets, integrate value added technologies, and
drive significant increases in efficiencies, output and profitability.
Additionally, 4Rivers is committed to commercializing the STT(R) technology
worldwide. STT, Magellan and Innovator are registered USPTO trademarks of Four
Rivers BioEnergy, Inc., all rights reserved.
This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements are based on
management's good faith views and expectations when made. Forward-looking
statements are inherently subject to known and unknown risks and uncertainties
which, in the case of the company, include raising adequate capital to
continue operations, technology and product development uncertainties,
competition, cost and availability of feedstock, and plant development and
manufacturing scale up. Actual results may differ, perhaps materially, from
those discussed in the forward-looking statements. The company discussed in
this release is not obligated to update its forward-looking statements or
comment on those differences. Readers are encouraged to refer to the recent
public filings of the company to further ascertain the risks associated with
the forward-looking statements. Readers are urged not to place undue reliance
upon such statements.
SOURCE Four Rivers BioEnergy Company Inc.
Gary Hudson, Senior Vice President, Operations, (270) 282-0926 or +44 161 408
0126, garyhudson@riv4ers.com; Laurel Moody, Investor Relations, Corporate
Profile, LLC, Tel (646) 810-0608, Email: lmoody@corporateprofile.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters